Different genes, different diabetes: Lessons from maturity-onset diabetes of the young

Annals of Medicine

Volumn 34, Issue 3, 2002, Pages 207-216

  Stride, Amanda ^a   Hattersley, Andrew T ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Genetic testing; Glucokinase; Hepatocyte nuclear factor 1 ; Hepatocyte nuclear factor 1 ; Maturity onset diabetes of the young; MOOY; RCAO; Renal cysts

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN PROMOTER FACTOR 1; LIPID; LIPOPROTEIN; NUCLEAR FACTOR I; SULFONYLUREA DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CELL RECEPTOR; DNA BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MLX PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; TCF1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

AUTOSOMAL DOMINANT DISORDER; BIRTH WEIGHT; BLOOD FLOW; CELL HETEROGENEITY; DIABETIC ANGIOPATHY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MATERNAL BLOOD; MATURITY ONSET DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS OF THE YOUNG; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET DISEASE; PHENOTYPE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; FEMALE; GENETICS; MALE; MUTATION; PANCREAS ISLET;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIRTH WEIGHT; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HOMEODOMAIN PROTEINS; HUMANS; ISLETS OF LANGERHANS; MALE; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035992825     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/ann.34.3.207.217     Document Type: Review

References (74)

1. Maturity onset diabetes of the young: From clinical description to molecular genetic characterization
2. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Provisional report of a WHO consultation
3. Diabetes mellitus and heredity
4. Maturity-onset diabetes of the young: A clinical history
5. Mild familial diabetes with dominant inheritance
6. Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young
7. Type 2 (non-insulin-dependent) diabetes. New genetics for old nightmares
8. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
9. Linkage of type 2 diabetes to the glucokinase gene
10. Gene for non-insulin-dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q
11. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q
12. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3)
13. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1)
14. Mutation in hepatocyte nuclear factor-1h gene (TCF2) associated with MODY
15. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
16. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
17. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed?
18. Beta-cell genes and diabetes: Molecular and clinical characterization of mutations in transcription factors
19. Familial hyperglycemia due to mutations in glucokinase. Definition of A subtype of diabetes mellitus
20. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI
21. Pancreatic islet glucose metabolism and regulation of insulin secretion
22. Glucokinase as glucose sensor and metabolic signal generator in panceatic β-cell and hepatocytes
23. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families
24. Mutations in the glucokinase gene of the fetus in reduced birthweight
25. Permanent neonatal diabetes mellitus clue to glucokinase deficiency: An reborn error of the glucose/insulin signaling pathway
26. Familial hyperinsulinism caused by an activating glucokinase mutation
27. Glucokinase mutations and Type 2 diabetes
28. MODY 2 presenting as neonatal hyperglycaemia: A need to reshape the definition of "neonatal diabetes"?
29. The genetic abnormality in the beta-cell determines the response to an oral glucose load
30. Clinical characteristics of subjects with a missense mutation in glucokinase
31. Assessment of insulin sensitivity in glucokinase-deficient subjects
32. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
33. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
34. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
35. The fetal insulin hypothesis: An alternative explanation of the association of low birth weight with diabetes and vascular disease
36. Intrauterine programming of adult disease
37. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations
38. Influence of maternal and fetal glucokinase mutations in gestational diabetes
39. Maternal diabetes alters birth weight in glucokinase deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretiton or insulin sensitivity
40. A rapid screening method for hepatocyte nuclear factor 1 alpha; prevalence in maturity-onset diabetes of the young and late-onset non insulin dependent diabetes
41. Mutations in the hepatocyte nuclear factor 1 α gene in MODY and early-onset NIDDM: Evidence for a mutational hotspot in exon 4
42. Novel mutations and a mutational hotspot in the MODY3 gene
43. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences
44. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1 beta gene associated with diabetes and renal dysfunction
45. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta
46. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta
47. Mutations in the HNF1-beta gene are associated with familial hypoplastic glomerulocystic kidney disease
48. Hepatocyte nuclear factor-1beta: A new kindred with renal cysts and diabetes and gene expression in normal human development
49. Splice site mutation in the hepatocyte nuclear factor-1 beta gene, IVS2nt + 1G > A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterus
50. Identification of a gain-of-function mutation in the HNF-1b gene in a Japanese family with MODY
51. A novel hepatocyte nuclear factor-1b (MODY 5) gene mutation in an Italian family with renal dysfunction and early-onset diabetes
52. Solitary functioning kidney and diverse genital tract malformations emphasize the variable phenotype associated with hepatocyte nuclear factor-1b mutations
53. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein
54. Missense mutations in the Insulin Promoter Factor 1 (IPF-1) gene predispose to Type 2 diabetes
55. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
56. Altered insulin secretory responses to glucose in diabetic and non-diabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
57. Beta-cell genes and diabetes: Quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations
58. A transcription factor regulatory circuit in differentiated pancreatic cells
59. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young
60. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20
61. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect
62. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY2) subjects
63. Impaired maximum microvascular hyperaemia in patients with MODY 3 (hepatocyte nuclear factor-1alpha gene mutations)
64. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor 1 alpha gene mutations: Evidence for pharmacogenetics in diabetes
65. Novel MODY3 mutations in the hepatic nuclear factor-1α gene: Evidence for a hyperexcitability of pancreatic β-cells to intravenous secretagogues in a glucose tolerant carrier of a P447L mutation
66. Insulin secretion and insulin sensitivity in diabetic subgroups: Studies in the prediabetic and diabetic state
67. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene
68. The present status of maturity-onset type diabetes of young people (MODY)
69. HNF-1alpha mutations in Mody
70. HNF1 alpha controls renal glucose reabsorption in mouse and man
71. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria
72. Mutation ia the HNF-4 alpha gene affects insulin secretion and triglyceride metabolism
73. Genotype/phenotype relationships in HNF-4alpha/MODY1: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
74. Predictive genetic testing in diabetes: A case study of multiple perspectives